Results from the study that identified the 11-gene set were published online today in Science Translational Medicine.
The test helps to identify metastatic colorectal cancer patients for whom treatment with Erbitux (cetuximab) or Vectibix (panitumumab) may be effective because their tumors carry no KRAS mutations.
DiaCarta will have the exclusive rights to develop a test for the early detection of colon cancer from stool samples and to commercialize it globally.
The new test promises lower cost, faster turnaround time, and easier implementation than current NIPT, which rely on next-generation sequencing or microarray analysis.
The technology compensates for genomic DNA amplified in qPCR gene expression measurements.
A study comparing DNA extracted from standardized blocks of FFPE showed variability among experienced molecular pathology labs.
PositiveID will issue $4 million in senior secured convertible promissory notes to institutional investor Dominion Capital, the firm announced today.
Melanoma test development firm DermTech is pulling its proposed initial public offering.
NEW YORK (GenomeWeb) – An international team of researchers has developed a qPCR-based assay to detect kidney transplant patients who are at high risk of acute rejection.
NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.
A new report offers ways for small, society publishers to transition to Plan S standards, ScienceInsider says.
A gas explosion sparked a fire at a Russian laboratory that stores dangerous pathogens, the Guardian reports.
Researchers turn to protein analysis to examine an ancient rhino sample, Smithsonian.com reports.
In PNAS this week: C2CD4A gene involved in insulin secretion, chromosome rearrangements in recurring S. aureus infections, and more.